Activated JNK acts on nuclear factor-κb (NF-κB) and activator protein-1 (AP-1) to produce more inflammatory factors, further reduce the sensitivity of insulin target cells to insulin, and eventually form a vicious cycle and aggravate insulin resistance (Bazin et al., 2012). The gene discussed is NFKB1; the disease is Insulin resistance.